Ligand Pharmaceuticals
LGND
#3341
Rank
A$6.41 B
Marketcap
A$321.54
Share price
3.84%
Change (1 day)
96.72%
Change (1 year)

Earnings for Ligand Pharmaceuticals (LGND)

Earnings in 2025 (TTM): A$0.24 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's current earnings are A$0.26 Billion. , an increase over its 2024 earnings that were of A$7.69 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ligand Pharmaceuticals from 1994 to 2025

Annual earnings

Year Earnings Change
2025 A$0.22 B2848.57%
2024 A$7.69 M-91.37%
2023 A$89.2 M-7.59%
2022 A$96.53 M4%
2021 A$92.82 M296.42%
2020 A$23.41 M-97.97%
2019 A$1.15 B275.62%
2018 A$0.30 B237.48%
2017 A$91.07 M49.05%
2016 A$61.1 M55.41%
2015 A$39.31 M36.87%
2014 A$28.72 M29.59%
2013 A$22.16 M1309.35%
2012 A$1.57 M-43.97%
2011 A$2.8 M-113.19%
2010 -A$21.29 Million59.86%
2009 -A$13.32 Million-61.33%
2008 -A$34.44 Million-58.75%
2007 -A$83.47 Million20.52%
2006 -A$69.26 Million81.27%
2005 -A$38.21 Million
2003 -A$26.6 Million-20.6%
2002 -A$33.5 Million4.38%
2001 -A$32.1 Million-48.83%
2000 -A$62.72 Million-19.74%
1999 -A$78.14 Million-19.06%
1998 -A$96.54 Million126.71%
1997 -A$42.59 Million-5.83%
1996 -A$45.22 Million136.23%
1995 -A$19.15 Million-33.97%
1994 -A$28.99 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$46.53 B 20,399.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$14.13 B 6,126.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$35.69 B 15,620.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$12.45 B 5,384.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-A$0.71 Billion-408.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$31.10 B 13,599.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$12.93 B 5,599.10%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$13.72 B 5,945.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
-A$85.84 Million-137.81%๐Ÿ‡บ๐Ÿ‡ธ USA